 |
glecaprevir and pibrentasvir |
|---|---|
| Trade Name | |
| Orphan Indication | Pediatric patients with chronic hepatitis C virus infection |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-09 00:00:00 |
| Sponsor | AbbVie, Inc.;1 Waukegan Road;North Chicago, Illinois, 60044 |
